|
From: |
Health District 3 - Southwest District Health (PHD3) |
|
Sent: |
5/20/2020 9:46:39 AM |
|
To: |
District Director (PHD3), Epidemiologist (PHD3), Family Health Director (PHD3), Community Health Director (PHD3), Environmental Health Director (PHD3), BT Program Manager (PHD3), Immunization Program Coordinator (PHD3), Food Program Coordinator (PHD3), Public Information Officer (PHD3), Primary Care Provider (PHD3), Specialist, Non-Primary Care (PHD3), Nurse (PHD3), Other Medical (PHD3), Veterinarian (PHD3), Dentist (PHD3), Pharmacy (PHD3), Other Agency/Business (PHD3), First Responder (PHD3), Political (PHD3), Other Public Health (PHD3), Media (PHD3), Board of Health (PHD3), Cardiology (PHD3), City Clerks (PHD3), Contract Physcians / Pharmacists (PHD3), County Clerks (PHD3), County Commissioners (PHD3), Dermatology (PHD3), Emergency Medicine (PHD3), Family Medicine (PHD3), Gastroenterology (PHD3), General Practice (PHD3), Hospital Administration (PHD3), Internal Medicine (PHD3), Laboratories (PHD3), Legislators (PHD3), Licensed Practical Nurse (PHD3), Mayors (PHD3), Medical Assistants (PHD3), Medical Reserve Corp (PHD3), Mental Health (PHD3), Military Public Health (PHD3), Neighboring Out-of-State Jurisdictions (PHD3), Neurology (PHD3), Nurse Practitioner (PHD3), Nursing Homes (PHD3), OB / GYN (PHD3), Oncology (PHD3), Ophthalmology (PHD3), Orthopedics (PHD3), Other (PHD3), Pathology (PHD3), Pediatrics (PHD3), Physician Assistant, Primary Care (PHD3), Podiatry (PHD3), Psychiatry / Psychology (PHD3), Public Health Nurse (PHD3), Pulmonary (PHD3), Radiology (PHD3), Registered Nurse (PHD3), Satellite Offices (PHD3), Surgeons (PHD3), Urology (PHD3), Ambulance Services (PHD3), Animal Control (PHD3), Coroners (PHD3), Emergency Department Administration (PHD3), Emergency Managers (PHD3), Emergency Medical Services (PHD3), Fire Departments (PHD3), HAZMAT (PHD3), Infection Control Practitioners (PHD3), Law Enforcement (PHD3), Administration (PHD3), Nurses (PHD3), School (PHD3), Assisted Living Facilities (PHD3), Businesses (PHD3), Chamber of Commerce (PHD3), Correctional Facilities (PHD3), Day Care Facilities (PHD3), Institutions of Higher Learning (PHD3), Morticians (PHD3), Newspapers (PHD3), Radio (PHD3), Television (PHD3), CDC HAN Coordinator (PHD3), Infectious Disease Physician (PHD3), PHD_Test (PHD3), Employee Health (PHD3), Infection Preventionist (PHD3), Homeless Shelters (PHD3), Substance Abuse Rehabilitation (PHD3), Pool Operator (PHD3) |
|
Subject: |
COVID-19 ADVISORY FOR HEALTH CARE PROVIDERS |
|
|
HEALTH ALERT NETWORK
HEALTH DISTRICT 3
COVID-19 ADVISORY FOR HEALTH CARE PROVIDERS
Southwest District Health Department Asks Providers to Report Multisystem Inflammatory Syndrome in Children Associated with Coronavirus Disease 2019
May 20, 2020
In early May 2020, the New York City Department of Health and Mental Hygiene received reports of children with multisystem inflammatory syndrome (MIS-C) and many of these patients required admission to the intensive care unit. As of May 12, 2020, the New York State Department of Health identified 102 patients (including patients from New York City) with similar presentations, many of whom tested positive for SARS-CoV-2 infection by RT-PCR or serologic assay. Additional reports of children presenting with severe inflammatory syndrome with a laboratory-confirmed case of COVID-19 or an epidemiological link to a COVID-19 case have been reported in other countries. As of May 18, no children with MIS-C have been reported to Idaho public health officials.
It is currently unknown if multisystem inflammatory syndrome is specific to children or if it also occurs in adults. There is limited information currently available about risk factors, pathogenesis, clinical course and treatment for MIS-C.
Recommendations
Healthcare providers who have cared or are caring for patients younger than 21 years of age meeting MIS-C criteria should report suspected cases to the Bureau of Communicable Disease Prevention Epidemiology Section (208) 334-5939 or Southwest District Health at (208) 455-5442.
Case Definition for Multisystem Inflammatory Syndrome in Children (MIS-C)
An individual aged <21 years presenting with subjective or measured fever of at least 38 C for 24 hours or more, laboratory evidence of inflammation (see note below), and evidence of clinically severe illness requiring hospitalization, with multisystem organ involvement (2 or more including cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological); AND
No alternative plausible diagnoses; AND
Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or COVID-19 exposure within the 4 weeks prior to the onset of symptoms.
Note: Evidence of inflammation including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and low albumin.
For additional information, please contact CDC’s 24-hour Emergency Operations Center at 770-488-7100.
Additional comments
Some individuals may fulfill full or partial criteria for Kawasaki disease but should be reported if they meet the case definition for MIS-C.
Consider MIS-C in any pediatric death with evidence of SARS-CoV-2 infection.
An archived CDC Clinician Outreach and Communication Activity (COCA) call on this topic is here: https://emergency.cdc.gov/coca/calls/2020/callinfo_051920.asp
|